Apellis Pharmaceuticals (APLS) Insider Trading & Ownership → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free APLS Stock Alerts $48.72 +1.08 (+2.27%) (As of 04/23/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Apellis Pharmaceuticals (NASDAQ:APLS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)14Amount OfInsider Selling(Last 12 Months)$51.20 M Get APLS Insider Trade Alerts Want to know when executives and insiders are buying or selling Apellis Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLS Insider Buying and Selling by Quarter Ad Whats On FinancePutin and other countries have a planDid you catch that bombshell Tucker Carlson interview with Vladimir Putin? It’s not about if you like Tucker or think Putin is the devil or whatever. It's all about the fact that the US dollar might be taking a back seat... and soon. Click to kickstart your journey to survive in the new economy Apellis Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/8/2024Pascal DeschateletsInsiderSell69,107$54.17$3,743,526.19 4/1/2024Timothy Eugene SullivanCFOSell4,000$58.66$234,640.00 3/19/2024A. Sinclair DunlopDirectorSell18,681$57.18$1,068,179.58 3/18/2024Mark Jeffrey DelongInsiderSell9,913$56.90$564,049.70 3/15/2024James George ChopasCAOSell184$56.46$10,388.64 3/13/2024Nur NicholsonInsiderSell11,220$57.56$645,823.20 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/1/2024Cedric FrancoisCEOSell250,000$64.11$16,027,500.00 3/1/2024Timothy Eugene SullivanCFOSell6,000$63.22$379,320.00 2/12/2024Adam J TownsendInsiderSell1,148$67.77$77,799.96 2/12/2024Cedric FrancoisCEOSell3,962$67.77$268,504.74 2/12/2024David O WatsonGeneral CounselSell781$67.77$52,928.37 2/12/2024Timothy Eugene SullivanCFOSell1,431$67.77$96,978.87 1/29/2024Cedric FrancoisCEOSell2,843$64.14$182,350.02 1/29/2024David O WatsonGeneral CounselSell906$64.14$58,110.84 1/29/2024Nur NicholsonInsiderSell835$64.14$53,556.90 1/22/2024Adam J TownsendInsiderSell3,413$65.00$221,845.00 1/22/2024Cedric FrancoisCEOSell13,431$65.00$873,015.00 1/22/2024David O WatsonGeneral CounselSell4,184$65.00$271,960.00 1/22/2024James George ChopasCAOSell1,061$65.00$68,965.00 1/22/2024Timothy Eugene SullivanCFOSell3,551$65.00$230,815.00 1/16/2024Cedric FrancoisCEOSell7,851$66.81$524,525.31 1/16/2024David O WatsonGeneral CounselSell4,240$66.81$283,274.40 1/16/2024James George ChopasCAOSell864$66.81$57,723.84 1/16/2024Jeffrey EiseleInsiderSell438$66.81$29,262.78 1/16/2024Timothy Eugene SullivanCFOSell2,235$66.81$149,320.35 1/4/2024Caroline BaumalInsiderSell2,751$60.05$165,197.55 12/26/2023Jeffrey EiseleInsiderSell68$57.86$3,934.48 12/19/2023David O WatsonGeneral CounselSell3,905$57.23$223,483.15 12/1/2023Lukas ScheiblerInsiderSell10,000$60.00$600,000.00 11/21/2023Cedric FrancoisCEOSell5,000$48.80$244,000.00 11/17/2023Alec MachielsDirectorSell1,250$47.74$59,675.00 11/8/2023Pascal DeschateletsInsiderSell12,000$47.27$567,240.00 10/23/2023James George ChopasCAOSell132$46.04$6,077.28 10/23/2023Mark Jeffrey DelongInsiderSell131$46.04$6,031.24 10/17/2023Alec MachielsDirectorSell1,250$48.50$60,625.00 10/9/2023Pascal DeschateletsInsiderSell12,000$40.38$484,560.00 9/18/2023Alec MachielsDirectorSell1,250$45.00$56,250.00 9/18/2023Nur NicholsonInsiderSell20,350$44.27$900,894.50 9/15/2023Alec MachielsDirectorSell1,250$45.34$56,675.00 9/8/2023Pascal DeschateletsInsiderSell12,000$42.87$514,440.00 At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK…9/1/2023Cedric FrancoisCEOSell150,000$41.75$6,262,500.00 8/31/2023James George ChopasCAOSell551$41.23$22,717.73 8/8/2023Pascal DeschateletsInsiderSell12,000$23.66$283,920.00 7/17/2023Alec MachielsDirectorSell1,250$64.79$80,987.50 7/10/2023Pascal DeschateletsInsiderSell12,000$84.55$1,014,600.00 7/3/2023David O WatsonGeneral CounselSell8,510$89.98$765,729.80 7/3/2023Timothy Eugene SullivanCFOSell6,779$89.97$609,906.63 6/20/2023Alec MachielsDirectorSell1,250$88.41$110,512.50 6/8/2023Pascal DeschateletsInsiderSell12,000$91.35$1,096,200.00 6/5/2023Timothy Eugene SullivanCFOSell69,779$88.80$6,196,375.20 6/1/2023Karen LewisInsiderSell5,000$86.00$430,000.00 5/17/2023Alec MachielsDirectorSell1,250$88.66$110,825.00 5/16/2023Cedric FrancoisCEOSell30,000$85.66$2,569,800.00 5/8/2023Pascal DeschateletsInsiderSell12,000$92.39$1,108,680.00 5/3/2023Adam J TownsendInsiderSell5,000$82.71$413,550.00 (Data available from 1/1/2013 forward) APLS Insider Trading Activity - Frequently Asked Questions Who is on Apellis Pharmaceuticals's Insider Roster? The list of insiders at Apellis Pharmaceuticals includes A. Sinclair Dunlop, Adam J Townsend, Alec Machiels, Caroline Baumal, Cedric Francois, David O Watson, Federico Grossi, James George Chopas, Jeffrey Eisele, Karen Lewis, Lukas Scheibler, Mark Jeffrey Delong, Morningside Venture Investment, Nicole D Perry, Nur Nicholson, Pascal Deschatelets, Timothy Eugene Sullivan, and Victoria L Brown. Learn more on insiders at APLS. What percentage of Apellis Pharmaceuticals stock is owned by insiders? 7.50% of Apellis Pharmaceuticals stock is owned by insiders. Learn more on APLS's insider holdings. Which Apellis Pharmaceuticals insiders have been selling company stock? The following insiders have sold APLS shares in the last 24 months: A. Sinclair Dunlop ($3,862,164.97), Adam J Townsend ($4,014,794.96), Alec Machiels ($1,244,512.50), Caroline Baumal ($165,197.55), Cedric Francois ($32,763,087.07), David O Watson ($2,350,586.56), Federico Grossi ($766,850.00), James George Chopas ($165,872.49), Jeffrey Eisele ($192,963.30), Karen Lewis ($957,418.90), Lukas Scheibler ($1,030,000.00), Mark Jeffrey Delong ($2,237,480.94), Nur Nicholson ($1,600,274.60), Pascal Deschatelets ($15,591,126.19), Timothy Eugene Sullivan ($7,897,356.05), and Victoria L Brown ($121,410.00). How much insider selling is happening at Apellis Pharmaceuticals? Insiders have sold a total of 1,243,708 Apellis Pharmaceuticals shares in the last 24 months for a total of $74,961,096.08 sold. More Insider Trading Tools from MarketBeat Related Companies: Ionis Pharmaceuticals Insider Transactions Elanco Animal Health Insider Transactions Jazz Pharmaceuticals Insider Transactions Cytokinetics Insider Transactions Blueprint Medicines Insider Transactions Viking Therapeutics Insider Transactions Cerevel Therapeutics Insider Transactions Intra-Cellular Therapies Insider Transactions Madrigal Pharmaceuticals Insider Transactions Organon & Co. Insider Transactions Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1Michael Burry Picked a Winner With GEN Restaurant Group This page (NASDAQ:APLS) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apellis Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
